istock-506815322_artjazz

artjazz / iStockphoto.com

2 August 2018Big Pharma

EMA scales back activities ahead of Brexit

The European Medicines Agency (EMA) has announced plans to temporarily further scale back and suspend activities in order to cope with a more significant staff loss from the agency’s relocation than was originally expected.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Parliament votes for UK to stay in EMA

23 July 2018 The UK Parliament has voted in favour of the UK’s continued participation in the European Medicines Agency.

No-deal Brexit: MHRA would take on EMA functions for UK

24 August 2018 The UK will fall outside of the European Medicines Agency in the event of a no-deal Brexit, leaving the Medicines and Healthcare Products Regulatory Agency to take on the functions currently undertaken by the EU for medicines on the UK market.

EMA cuts MHRA out of drug reviews ahead of Brexit

4 September 2018 The European Medicines Agency has reportedly put a stop to the UK’s role in evaluating new EU medicines for sale as Brexit looms.

More on this story

Parliament votes for UK to stay in EMA

23 July 2018 The UK Parliament has voted in favour of the UK’s continued participation in the European Medicines Agency.

No-deal Brexit: MHRA would take on EMA functions for UK

24 August 2018 The UK will fall outside of the European Medicines Agency in the event of a no-deal Brexit, leaving the Medicines and Healthcare Products Regulatory Agency to take on the functions currently undertaken by the EU for medicines on the UK market.

EMA cuts MHRA out of drug reviews ahead of Brexit

4 September 2018 The European Medicines Agency has reportedly put a stop to the UK’s role in evaluating new EU medicines for sale as Brexit looms.

More on this story

Parliament votes for UK to stay in EMA

23 July 2018 The UK Parliament has voted in favour of the UK’s continued participation in the European Medicines Agency.

No-deal Brexit: MHRA would take on EMA functions for UK

24 August 2018 The UK will fall outside of the European Medicines Agency in the event of a no-deal Brexit, leaving the Medicines and Healthcare Products Regulatory Agency to take on the functions currently undertaken by the EU for medicines on the UK market.

EMA cuts MHRA out of drug reviews ahead of Brexit

4 September 2018 The European Medicines Agency has reportedly put a stop to the UK’s role in evaluating new EU medicines for sale as Brexit looms.

More features

President Trump 2.0: Five major areas to watch

Sandoz lands reduced antitrust award of $70m

New president’s to-do list: Patent bills, non-competes, USPTO director?

Sanofi subsidiary fends off $450m trade secrets case

Regulatory expert joins White & Case

Teva faces $500m fine for antitrust breaches over MS drug

UK Budget: A missed opportunity?

Pfizer infringed haemophilia therapy patent, says court